LifeVantage Announces Financial Results for the First Quarter Fiscal 2027
Key Highlights
- ➤Revenue $37.1 million, down 22.0% year over year
- ➤Net loss $0.02 per diluted share versus $0.17 profit
- ➤Active accounts fell 19.0% to 98,000 year over year
- ➤Adjusted EBITDA $1.9 million versus $3.9 million previously
- ➤$58.5 million remained under the $60 million repurchase authorization
Expert Statements
Terrence Moorehead, President and Chief Executive Officer of LifeVantage Corporation
“Despite a challenging quarter, LifeVantage has significant untapped potential, and we now have a clear strategy designed to capture it.”
Terrence Moorehead, President and Chief Executive Officer of LifeVantage Corporation
“Our focus is on transforming LifeVantage into a more brand-driven, consumer-focused company, supported by a modern digital platform and an expanding community of consumers and brand advocates.”
Terrence Moorehead, President and Chief Executive Officer of LifeVantage Corporation
“At the same time, we are creating a more focused and efficient operating model and strengthening the underlying economics of the business.”
Terrence Moorehead, President and Chief Executive Officer of LifeVantage Corporation
“We have a lot of work to do, and building the company we envision will take time, but we have a differentiated foundation, a clear roadmap and a strong sense of urgency around execution.”
Terrence Moorehead, President and Chief Executive Officer of LifeVantage Corporation
“The actions we are taking are designed to build a stronger, more relevant LifeVantage and create sustainable long-term value for our shareholders.”
SALT LAKE CITY, Nov. 09, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its quarter ended September 30, 2026.
First Quarter Fiscal 2027 Summary*: * Revenue was $37.1 million, a decrease of 22.0% from the prior year period; * Revenue in the Americas decreased 22.2%, and revenue in Asia/Pacific & Europe decreased 21.2%; * Net loss per diluted share was $0.02, versus net income per diluted share of $0.17 a year ago; * Adjusted earnings per diluted share was $0.05, compared to $0.18 a year ago; and * Adjusted EBITDA was $1.9 million compared to $3.9 million a year ago. * All comparisons are on a year over year basis and compare the first quarter of fiscal 2027 to the first quarter of fiscal 2026, unless otherwise noted.
Get started
Create a free account to read the full story.